Webinar: Animal trade and human health in an era of COVID-19 and Antimicrobial Resistance
The world is experiencing an unprecedented pandemic and related social and economic crisis. COVID-19 follows other major zoonotic diseases of the last two decades, including Severe Acute Respiratory Syndrome (SARS), Avian influenza (bird flu), H1N1 (swine flu), Middle East Respiratory Syndrome (MERS) and Ebola, and it is likely that zoonotic pandemics will be increasingly frequent events.
At the same time, the global problem of antimicrobial resistance – or ‘superbugs’ – continues to grow. It is estimated that at least 700,000 people die every year as a result of drug-resistant diseases, and that if no action is taken, this could rise to 10 million deaths a year by 2050. The misuse of antimicrobials in animal production is one of the causes of this problem.
What are the chances of finding coherence across these areas of law and policy, at both national and international levels? Might COVID-19 catalyse positive and lasting change?
In this webinar, Professor Barbara McPake and Dr Angus Campbell (Nossal Institute for Global Health, Melbourne School of Population and Global Health) Professor Christine Parker (Melbourne Law School) and Associate Professor Jonathan Liberman (Melbourne Law School and Melbourne School of Population and Global Health) discuss the relationships between the trade in animals – both livestock and wildlife – and human health, and the interconnections between humans, animals, plants and our shared environment.
Registrants will receive a link to the recorded discussion and will be able to watch the recorded portion in advance of the event if they prefer.
Health Law and Ethics Network